Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Closed 11-25 16:00:00 EST

1,283.77

+2.62

+0.20%

High1,295.93	Low1,274.48	Vol80.41M
Open1,281.23	D1 Closing1,281.15	Amplitude1.67%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O1.40B	T/O Rate--	Tradable Shares0.00
P/B3.184849	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1283.7709,"timestamp":1732568399999,"preClose":1281.1522,"halted":0,"volume":80406442,"delay":0,"changeRate":0.002044,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.618652,"latestTime":"11-25 16:00:00 EST","open":1281.2262,"high":1295.9287,"low":1274.4751,"amount":1401533518.239494,"amplitude":0.016746,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732611600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.184849,"peRate":-304.851413,"turnoverRate":0.026679,"increases":9,"decrements":5,"flats":0,"marketCap":148199794436,"floatMarketCap":147465174831},"requestUrl":"/m/hq/s/BK4583","defaultTab":"news","newsList":[{"id":"2486059060","title":"Gilead acquires investigational HIV vaccine from Spanish biotech Aelix","url":"https://stock-news.laohu8.com/highlight/detail?id=2486059060","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486059060?lang=en_us&edition=fundamental","pubTime":"2024-11-26 03:11","pubTimestamp":1732561896,"startTime":"0","endTime":"0","summary":"MicroStockHub/E+ via Getty Images Gilead Sciences  has acquired assets related to a therapeutic HIV vaccine under development from Barcelona, Spain-based biotech Aelix Therapeutics. The vaccine uses the HTI immunogen which is \"designed to redirect the immune response toward the most vulnerable regions of HIV,\" according","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2152883587/image_2152883587.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2152883587/image_2152883587.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4331369-gilead-acquires-investigational-hiv-vaccine-spanish-biotech-aelix","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4583","LU2468319806.SGD","IE00BSNM7G36.USD","LU0889565916.HKD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1066053197.SGD","BK4568","LU1839511570.USD","LU2087621335.USD","BK4588","LU0109394709.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","GILD","LU0058720904.USD","BK4566","BK4550","BK4585","LU0289739699.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","BK4578","LU1571399168.USD","BK4532","BK4139","LU1585245621.USD","IE00B19Z3581.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"2486443080","title":"Exploring Three High Growth Tech Stocks In The United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2486443080","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486443080?lang=en_us&edition=fundamental","pubTime":"2024-11-25 22:15","pubTimestamp":1732544125,"startTime":"0","endTime":"0","summary":"The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are projected to grow by 15% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.Overview: Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of novel therapeutics using ribonucleic acid interference technology, with a market cap of $31.59 billion.Overview: Gilead Sciences, Inc. is a biopharmaceutical company that focuses on discovering, developing, and commercializing medicines for unmet medical ne","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/._HFmWFPcwt6muyT_tZE7g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b394072c431426666ba19d9f9857f297","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/._HFmWFPcwt6muyT_tZE7g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b394072c431426666ba19d9f9857f297"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-three-high-growth-tech-141525525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","IE00BF5LJ272.USD","LU2125910500.SGD","BK4566","BK4211","LU0320765992.SGD","LU1066051498.USD","BK4550","LU1430594728.SGD","IE0002270589.USD","GILD","BK4585","ALNY","BK4134","BK4568","BK4578","IE00BZ1G4Q59.USD","BK4548","IE00B19Z3581.USD","BK4583","LU0234570918.USD","BK4532","LU0058720904.USD","GLOB","IE00B0169N27.USD","LU1066053197.SGD","LU1585245621.USD","LU2468319806.SGD","UBCP","BK4139","LU1571399168.USD","LU0109394709.USD","LU2045819591.USD","LU1839511570.USD","LU2087621335.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2485298273","title":"3 ‘Buy’ stocks and 2 ‘Hold’ stocks according to Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298273","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485298273?lang=en_us&edition=fundamental","pubTime":"2024-11-22 23:58","pubTimestamp":1732291099,"startTime":"0","endTime":"0","summary":"3D_generator Oppenheimer analysts provided technical analysis for five stocks, all rated “outperform.” This is “technical color” for stocks discussed in Oppenheimer’s research call by analysts. Buy Gilead Sciences  – Uptrend  This stock has a trend with “top-down headwinds from a relatively weak biotechnology  industry.” Corning  – Uptrend  The stock is attempting to break through its April 2021 peak. “It’s also notable the stock is still trading below its year-2000 high at $113,” analysts wrote. But its bullish trend and high-momentum “argues for a definitive breakout to a new cycle high over the coming weeks to months.” McGrath RentCorp  – Reversing higher The stock has been showing improvement since its late-October breakout above its 200-day average. However, its lower momentum score “leaves something to be desired,” analysts said. Hold Alcon  – Reversing lower The stock’s trend broke below its $89 resistance , and analysts see $82 as imminent support. RxSight  – Downtrend  This st","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/520290362/image_520290362.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/520290362/image_520290362.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4322049-3-buy-stocks-and-2-hold-stocks-according-to-oppenheimer","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU2265009873.SGD","BK4148","BK4583","RXST","LU0289739699.SGD","BK4104","LU2087621335.USD","BK4198","GLW","LU0234570918.USD","BK4566","LU1839511570.USD","LU1066053197.SGD","IE00BSNM7G36.USD","MGRC","ALC","LU0320765992.SGD","LU1585245621.USD","BK4534","LU2468319806.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4550","BK4585","LU0889565916.HKD","BK4578","BK7094","XBI","BK4581","LU0058720904.USD","BK4512","LU0109394709.USD","LU0348723411.USD","BK4139","BK4539","LU1066051498.USD","ALC.AU","LU1571399168.USD","BK4127","OPY","GILD","BK4532","IE00BZ1G4Q59.USD","BK4568","IE00BFMHRM44.USD","IE0002270589.USD","BK4588","LU1430594728.SGD","LU1804176565.USD","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2485260330","title":"Health care sector had the most stocks with 4-week low and RSI below 30 since spring","url":"https://stock-news.laohu8.com/highlight/detail?id=2485260330","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485260330?lang=en_us&edition=fundamental","pubTime":"2024-11-22 23:40","pubTimestamp":1732290008,"startTime":"0","endTime":"0","summary":"Two health care stocks that look “timely,” according to Krinsky:  Both Bristol Myers  – Up 38.12% in the last six months. Gilead Sciences  – Up 32.48% in the last six months.  Both have displayed bearish-to-bullish turnarounds in their charts over the last few quarters, Krinsky said. “The recent consolidations make both of them timely here, in our view.”","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1251892842/image_1251892842.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1251892842/image_1251892842.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4321978-health-care-sector-had-the-most-stocks-with-4-week-low-and-rsi-below-30-since-spring","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1989771016.USD","IE0002270589.USD","LU2087621335.USD","LU2125154778.USD","LU0889565916.HKD","BK4578","BK4139","IE0009355771.USD","BK4585","BK4007","IE00B2B36J28.USD","LU0225284248.USD","BK4534","XLV","LU2133065610.SGD","LU0320765992.SGD","LU0114720955.EUR","LU2242646821.SGD","IHI","XBI","LU1032466523.USD","LU1430594728.SGD","GILD","BK4588","LU2125154935.USD","LU1670710588.SGD","LU1670711040.USD","RSI","LU1718418525.SGD","IE0002141913.USD","IE00BKVL7J92.USD","LU0321505868.SGD","LU0058720904.USD","BK4559","LU0234570918.USD","LU0061475181.USD","LU1261432733.SGD","BK4583","LU1670710661.SGD","LU1323610961.USD","BMY","BK4550","IE00BJT1NW94.SGD","LU0306806265.USD","LU1291159041.SGD","BK4150","IE00BFTCPJ56.SGD","LU1839511570.USD"],"gpt_icon":0},{"id":"2485265037","title":"Viatris Fined $1.9 Million Over Alleged Violation of Antitrust Restrictions","url":"https://stock-news.laohu8.com/highlight/detail?id=2485265037","media":"MT Newswires Live","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485265037?lang=en_us&edition=fundamental","pubTime":"2024-11-22 22:02","pubTimestamp":1732284138,"startTime":"0","endTime":"0","summary":"Viatris  has been fined 1.5 million UK pounds  by the UK's Competition and Markets Authority for failing to comply with an order obtaining government approval before making staff changes and failing to report the breach, the regulator said Friday.The penalty was imposed in response to Viatris' sale of the European right to its hormone replacement therapy treatments Duphaston and Femoston to Theramex, which the regulator said could reduce competition.The regulator said Viatris breached restrictions imposed on it during an investigation by \"implementing changes to key members of its UK management team\" without consent and failing to notify authorities of the breach.Viatris did not immediately reply to MT Newswires' request for comment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","LU1839511570.USD","BK4583","LU2087621335.USD","BK4007","VTRS"],"gpt_icon":0},{"id":"2485728252","title":"BUZZ-U.S. STOCKS ON THE MOVE-Gold miners Ross Stores, NetApp","url":"https://stock-news.laohu8.com/highlight/detail?id=2485728252","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485728252?lang=en_us&edition=fundamental","pubTime":"2024-11-22 20:46","pubTimestamp":1732279575,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Gold miners Ross Stores, NetAppEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1883866441.USD","IE00B19Z8X17.USD","LU0633140727.USD","LU2210149790.SGD","LU1815336760.USD","LU0880133367.SGD","ROST","LU0708995583.HKD","BK4558","RUN","LU2257852520.SGD","INTU","LU0823414551.USD","LU1852331112.SGD","LU2361044865.SGD","SGXZ99366536.SGD","LU0128525689.USD","89618","NEM","LU0543330483.HKD","BK4504","LU0545562505.USD","LU0957791311.USD","LU2023251221.USD","IE00BQXX3C00.GBP","LU1023059493.AUD","LU1037948541.HKD","VTRS","LU2498475776.HKD","LU0444973449.USD","BK4502","LU1769817096.USD","SG9999001424.SGD","V","BK4587","LU0865486749.SGD","BK4583","SG9999018857.SGD","BK4559","NTAP","LU0724618789.USD","LU0654597011.USD"],"gpt_icon":1},{"id":"2485225988","title":"Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program","url":"https://stock-news.laohu8.com/highlight/detail?id=2485225988","media":"TipRanks","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485225988?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:35","pubTimestamp":1732275353,"startTime":"0","endTime":"0","summary":"Unlock your investing potential with TipRanks Premium - Now At 40% OFF!Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. Hookipa Pharma price target lowered to $48 from $50 at RBC Capital. Hookipa Pharma Reports Q3 Earnings Amid Strategic Changes. Closing Bell Movers: Applied Materials down 6% after earnings, guidance. JMP Securities healthcare analysts hold an analyst/industry conference call","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/hookipa-pharma-announces-workforce-reduction-113553263.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hookipa-pharma-announces-workforce-reduction-113553263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2087621335.USD","LU1585245621.USD","BK4532","BK4505","BK4588","LU2468319806.SGD","BK4566","LU0109394709.USD","LU1066053197.SGD","HOOK","BK4139","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","BK4583","BK4550","LU0234570918.USD","LU1430594728.SGD","BK4585","BK4568","IE00BKVL7J92.USD","LU0889565916.HKD","LU0058720904.USD","LU0289739699.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","GILD","LU1571399168.USD","LU1839511570.USD","BK4578","IE00BSNM7G36.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2485700255","title":"Viatris fined £1.5M for failure to comply with CMA order","url":"https://stock-news.laohu8.com/highlight/detail?id=2485700255","media":"seekingalpha","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485700255?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:26","pubTimestamp":1732274818,"startTime":"0","endTime":"0","summary":"Frank Brennan/iStock via Getty Images  Generic drugmaker Viatris  has been 1.5M by the U.K.'s Competition and Markets Authority  for failing to comply with compulsory restrictions imposed during the regulator’s review of its deal with Theramex. In Oct. 2023, Viatris  agreed to divest its rights to women’s health products, Duphaston and Femoston, to Theramex. Duphaston and Femoston, which comprise progesterone and estrogen receptor agonists, are prescribed as hormone replacement therapy  to help relieve menopause symptoms. Following a Phase 1 probe, in April 2024, the CMA said the deal would likely hurt competition in the HRT market. The antitrust regulator imposed an ‘Initial Enforcement Order’ which sought to prevent any action which could prejudice its inquiry or any potential remedies that the CMA might impose. The regulator said Viatris  breached these restrictions by implementing changes to key members of its UK management team without the CMA’s consent, and then failed to notify ","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2142910891/image_2142910891.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2142910891/image_2142910891.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4320334-viatris-fined-15m-for-failure-to-comply-with-cma-order","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4583","LU1839511570.USD","BK4585","BK4588","BK4211","CMA","LU2087621335.USD","BK4589","VTRS","BK4207","BK4007","HRT","BK4130"],"gpt_icon":0},{"id":"2485255227","title":"BUZZ-Viatris falls after $1.9 mln fine by UK watchdog","url":"https://stock-news.laohu8.com/highlight/detail?id=2485255227","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485255227?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:24","pubTimestamp":1732274648,"startTime":"0","endTime":"0","summary":"BUZZ-Viatris falls after $1.9 mln fine by UK watchdog** Shares of drugmaker Viatris Inc VTRS.O down 2.6% at $12.91 premarket** Britain's Competition and Markets Authority  fines VTRS 1.5 mln pounds  for breaching legally binding restrictions during its probe into Theramex's purchase of two Viatris product ranges** CMA says VTRS made unapproved changes to key UK staff  without the regulator's consent, and failed to report the breach** VTRS did not immediately respond to a Reuters request for comment** As of last close, stock has risen 22.4% YTD vs. 6.5% increase in the S&P 500 pharmaceuticals sub index .SPLRCCARD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","LU1839511570.USD","BK4007","BK4585","VTRS","BK4588","BK4583"],"gpt_icon":0},{"id":"2485253562","title":"Quest Diagnostics Inc : Leerink Partners Raises Target Price to $169 From $165","url":"https://stock-news.laohu8.com/highlight/detail?id=2485253562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485253562?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:59","pubTimestamp":1732273192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT0FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1854103824.USD","BK4588","LU1854104046.USD","BK4583","DGX","BK4567","BK4196"],"gpt_icon":0},{"id":"2485232954","title":"UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe","url":"https://stock-news.laohu8.com/highlight/detail?id=2485232954","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485232954?lang=en_us&edition=fundamental","pubTime":"2024-11-22 17:57","pubTimestamp":1732269464,"startTime":"0","endTime":"0","summary":"Nov 22 (Reuters) - Britain's competition watchdog fined U.S. firm Viatris    1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","VTRS","BK4585","CMA","BK4588","BK4589","BK4007","LU1839511570.USD","BK4211","LU2087621335.USD","BK4583"],"gpt_icon":0},{"id":"2485234360","title":"BRIEF-UK's CMA Fines Viatris £1.5 Mln For Failure To Comply With CMA Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2485234360","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485234360?lang=en_us&edition=fundamental","pubTime":"2024-11-22 17:35","pubTimestamp":1732268147,"startTime":"0","endTime":"0","summary":"Nov 22  - UK's CMA:    * UK'S CMA: VIATRIS FINED 1.5M FOR FAILURE TO COMPLY WITH CMA ORDER   * UK'S CMA: CMA FOUND THAT VIATRIS FAILED TO COMPLY WITH COMPULSORY RESTRICTIONS IMPOSED DURING CMA’S REVIEW OF ITS DEAL WITH THERAMEXFurther company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMA","BK4207","VTRS","BK4583","BK4007","BK4585","LU1839511570.USD","BK4588","LU2087621335.USD","BK4211","BK4589"],"gpt_icon":0},{"id":"2485231296","title":"UK's Cma: Cma Found That Viatris Failed to Comply With Compulsory Restrictions Imposed During Cma’s Review of Its Deal With Theramex","url":"https://stock-news.laohu8.com/highlight/detail?id=2485231296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485231296?lang=en_us&edition=fundamental","pubTime":"2024-11-22 17:32","pubTimestamp":1732267953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MS1AC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4583","LU1839511570.USD","BK4007","VTRS","LU2087621335.USD"],"gpt_icon":0},{"id":"2485421932","title":"SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket","url":"https://stock-news.laohu8.com/highlight/detail?id=2485421932","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485421932?lang=en_us&edition=fundamental","pubTime":"2024-11-22 06:01","pubTimestamp":1732226472,"startTime":"0","endTime":"0","summary":"SIGA Technologies' stock has declined 37% since my \"speculative buy\" recommendation in August, driven by a muted response to the mpox outbreak.The initial recommendation was based on the WHO's mpox em","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1302640919/image_1302640919.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1302640919/image_1302640919.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4739435-siga-technologies-expansion-into-mabs-is-smart-but-eggs-remain-in-one-basket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["SIGA","BK4583","BK4007"],"gpt_icon":0},{"id":"2485350415","title":"Gilead price target raised to $96 from $70 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2485350415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485350415?lang=en_us&edition=fundamental","pubTime":"2024-11-21 23:25","pubTimestamp":1732202715,"startTime":"0","endTime":"0","summary":"UBS raised the firm’s price target on Gilead (GILD) to $96 from $70 and keeps a Neutral rating on the shares. The firm increased HIV PrEP and Livde...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-96-from-70-at-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-96-from-70-at-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4566","LU0320765992.SGD","LU1066051498.USD","BK4550","LU1430594728.SGD","IE0002270589.USD","GILD","BK4585","BK4568","BK4578","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4583","LU0234570918.USD","BK4532","LU0058720904.USD","LU1066053197.SGD","LU1585245621.USD","LU2468319806.SGD","BK4139","LU1571399168.USD","LU0109394709.USD","LU1839511570.USD","LU2087621335.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2485411746","title":"Are Investors Undervaluing Siga Technologies (SIGA) Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2485411746","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485411746?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200013,"startTime":"0","endTime":"0","summary":"Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the \"Value\" category. When paired with a high Zacks Rank, \"A\" grades in the Value category are among the strongest value stocks on the market today.Siga Technologies  is a stock many investors are watching right now.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-undervaluing-siga-technologies-siga-144013768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4211","SIGA","ISBC","BK4583"],"gpt_icon":0},{"id":"2485725499","title":"Vitaris fined in Morocco over merger notification, sources say","url":"https://stock-news.laohu8.com/highlight/detail?id=2485725499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485725499?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:47","pubTimestamp":1732196846,"startTime":"0","endTime":"0","summary":"By Ahmed Eljechtimi      RABAT, Nov 21  - U.S. pharmaceutical giant Viatris Inc    has been fined 7.58 million dirhams  by Morocco's competition regulator for failing to notify it regarding its merger, two official sources said on Thursday.   Viatris was formed by the merger of Mylan, which has a subsidiary in Morocco, and Pfizer's    Upjohn business in 2020.   The fine, equivalent to 2.5% Viatris; revenue in Morocco last year, has already been paid to the Moroccan treasury, the sources said, requesting anonymity.    Viatris also declined to appeal the decision, the sources said.    Viatris did not immediately respond to a Reuters emailed request for comment.    The regulator is examining other mergers where Moroccan authorities have not been notified, one of the sources said. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","SG9999001176.SGD","BK4533","VTRS","LU0234572021.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0289739699.SGD","LU2087621335.USD","LU0321505439.SGD","BK4585","BK4007","LU0225284248.USD","BK4534","IE00B19Z3B42.SGD","LU1066051498.USD","LU0868494617.USD","LU0225771236.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU1894683264.USD","SG9999002224.SGD","LU1894683348.USD","BK4599","BK4568","LU1057294990.SGD","LU0985481810.HKD","BK4588","LU1839511570.USD","SGXZ57979304.SGD","SG9999013999.USD","SG9999011175.SGD","LU0321505868.SGD","LU0058720904.USD","BK4581","LU0306807586.USD","BK4583","LU0122379950.USD","IE00BBT3K403.USD","SG9999001176.USD","PFE","LU1066053197.SGD","LU1023059063.AUD","LU0170899867.USD","SG9999002232.USD","IE000M9KFDE8.USD","BK4550","LU1883839398.USD","LU0306806265.USD","BK4592"],"gpt_icon":1},{"id":"2485757881","title":"Virax Biolabs Sees Asset Growth Amid Financial Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2485757881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485757881?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:29","pubTimestamp":1732138176,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Class A (VRAX) has released an update. Virax Biolabs Group Ltd. Class A has reported an increase in total assets and stock...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-sees-asset-growth-amid-financial-loss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-sees-asset-growth-amid-financial-loss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4175","VRAX","BK4583"],"gpt_icon":0},{"id":"2485175154","title":"Envista Announces Release of 2023 Sustainability Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2485175154","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485175154?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:10","pubTimestamp":1732137000,"startTime":"0","endTime":"0","summary":"BREA, Calif., Nov. 20, 2024 /PRNewswire/ -- Envista Holdings Corporation  today announced the release of its 2023 Sustainability Report, outlining its continued efforts to integrate environmental, social, and governance  considerations into its mission to digitize, personalize, and democratize dental care. The full report can be found HERE.\"Our efforts to promote improved environment, social, and governance initiatives are central to how we support our stakeholders. Through the lens of our key areas of focus – Delivering Quality and Access; Supporting Our People and Community; Safeguarding the Environment; Centering Ethics and Compliance; and Practicing Good Governance – we have maintained steady progress in finding ways to improve how we work,\" said Paul Keel, CEO ofEnvista. \"As we release our fourth annual sustainability report, it is a pleasure to share the many ways in which we have delivered improved sustainability outcomes across our business.\"","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YUQW7SIDzdBoRQhKNHHJng--~B/aD0xMzI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/826fe20d526113db965f1195884c6ce7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YUQW7SIDzdBoRQhKNHHJng--~B/aD0xMzI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/826fe20d526113db965f1195884c6ce7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/envista-announces-release-2023-sustainability-211000754.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envista-announces-release-2023-sustainability-211000754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ESG","EBS","BK4583","LU0477156797.USD","BK4082","LU0130103400.USD","NVST","LU1201861165.SGD","LU0648000940.SGD","GRO","LU0130518102.USD"],"gpt_icon":0},{"id":"2484434115","title":"GeoVax Labs (GOVX) Receives a Buy from Noble Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484434115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484434115?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:05","pubTimestamp":1732107932,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on GeoVax Labs (GOVX – Research Report) today and set a price target of $12.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/geovax-labs-govx-receives-a-buy-from-noble-financial-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/geovax-labs-govx-receives-a-buy-from-noble-financial-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBL","BK4139","GOVX","BK4583"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}